Outcomes of vagal nerve stimulation in a pediatric population: A single center experience  Camilla Yu, Sriram Ramgopal, Mark Libenson, Imane Abdelmoumen,

Slides:



Advertisements
Similar presentations
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Advertisements

Ian Morrison, Saif S.M. Razvi  Seizure - European Journal of Epilepsy 
Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs) 
Tong Chen, Liang Guo  Seizure - European Journal of Epilepsy 
Vagus nerve stimulation in pediatric epileptic syndromes
Perri Carlson, Kathryn Nicholson Perry 
Post-traumatic seizures—A prospective study from a tertiary level trauma center in a developing country  Amit Thapa, Sarat P. Chandra, Sumit Sinha, V.
Antiepileptic drug therapy the story so far
Brain stimulation as a neuromodulatory epilepsy therapy
Effects of levetiracetam monotherapy on sperm parameters and sex hormones: Data from newly diagnosed patients with epilepsy  Mustafa Ceylan, Ahmet Yalcin,
Has disability discrimination legislation changed the legal framework for epilepsy in the United Kingdom?  Philip Lee  Seizure - European Journal of Epilepsy 
Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study  Chen-Shu Chang, Chun-Hui Liao, Che-Chen Lin, Hsien-Yuan.
Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: A meta- analysis  Yin-Xi Zhang, Chun-Hong Shen, Qi-Lun Lai, Gao-Li Fang, Wen-Jie.
Todd W. Lyons, Kara B. Johnson, Kenneth A. Michelson, Lise E
Bhimanagouda Patil, Agyepong Oware 
Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis 
Zheng Ping, Xu Ji-Wen, Wang Gui-Song, Zhou Hong-Yu, Tian Xin 
Presentation of adult mitochondrial epilepsy
Coral M. Stredny, Nicholas S. Abend, Tobias Loddenkemper 
Do epilepsy specialist nurses use a similar history-taking process as consultant neurologists in the differential diagnosis of patients presenting with.
Anshuman Sengupta, Ali Mahmoud, Shwe Z. Tun, Peter Goulding 
Predicting success of vagus nerve stimulation (VNS) from EEG symmetry
C. C. de Vos, L. Melching, J. van Schoonhoven, J. J. Ardesch, A. W
Clinical features and outcome of super-refractory status epilepticus: A retrospective analysis in West China  Yaohua Li, Linyu Tian, Tianfang Zeng, Jiani.
Hyponatremia following esclicarbazepine therapy
S. Kılınç, C. Campbell  Seizure - European Journal of Epilepsy 
Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy  Ting Zhao, Ming-yue Sun, Pei-min Yu, Guo-xing.
Seizure - European Journal of Epilepsy
Etiologic features of newly diagnosed epilepsy: Hospital-based study of 892 consecutive patients in West China  Yang Si, Ling Liu, Jia Hu, Jie Mu, Jia-jia.
Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control  Yang Yuan, Wang Xiang, Liu Yanhui, Liang Ruofei, Liu.
Smoking reduces serum levels of lamotrigine
Pediatric first time non-febrile seizure with focal manifestations: Is emergent imaging indicated?  N. Aprahamian, M.B. Harper, S.P. Prabhu, M.C. Monuteaux,
Seizure freedom with VNS monotherapy: A case report
Depression and anxiety in childhood epilepsy: A review
What patients say about living with psychogenic nonepileptic seizures: A systematic synthesis of qualitative studies  Gregg H. Rawlings, Markus Reuber 
Rui Wang, Hong-Zhi Guan, Hai-Tao Ren, Wei Wang, Zhen Hong, Dong Zhou 
Self-management interventions for epilepsy in people with intellectual disabilities: A scoping review  Michelle Dannenberg, Silvana E. Mengoni, Bob Gates,
Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison  Zhu Li-na , Chen.
Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: Cohort study using the General Practice Research Database 
Use of the Precaution Adoption Process Model to examine predictors of osteoprotective behavior in epilepsy  John O. Elliott, Brenda F. Seals, Mercedes.
Amplitude-integrated EEG for detection of neonatal seizures: a systematic review  Abhijeet Rakshasbhuvankar, Saritha Paul, Lakshmi Nagarajan, Soumya Ghosh,
White matter stimulation for the treatment of epilepsy
Epileptic spasms: Evidence for oral corticosteroids and implications for low and middle income countries  Sharika V. Raga, Jo M. Wilmshurst  Seizure -
Ali A. Asadi-Pooya, Mehrdad Emami, Alireza Nikseresht 
Oliver Faust, U. Rajendra Acharya, Hojjat Adeli, Amir Adeli 
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Clinical outcome following medical treatment of cavernous malformation related epilepsy  Yoonju Lee, Kyoo Ho Cho, Hye Ihn Kim, Seung-Koo Lee, Yang-Je.
Sudden death in epilepsy: Insights from the last 25 years
Rescue Medications in Epilepsy Patients: A Family Perspective
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Anina du Toit, Chrisma Pretorius 
HD-tDCS in refractory lateral frontal lobe epilepsy patients
S100B proteins in febrile seizures
Self reported adverse effects of mono and polytherapy for epilepsy
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy  Patrizia Pulitano, Valentina Franco, Oriano Mecarelli,
Antiepileptic drug use in Austrian nursing home residents
Lindsey Hunter, Peter Sidebotham, Richard Appleton, Colin Dunkley 
Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy  Andreas V. Alexopoulos, Prakash Kotagal, Tobias Loddenkemper,
Seizure - European Journal of Epilepsy
Association of the genetic polymorphisms in pre-microRNAs with risk of childhood epilepsy in a Chinese population  Yang Li, Jinqiu Wang, Chunming Jiang,
Vagal nerve stimulation: Relationship between outcome and electroclinical seizure pattern  Marina Casazza, Giuliano Avanzini, Paolo Ferroli, Flavio Villani,
Seizure - European Journal of Epilepsy
Johan Zelano, Eva Kumlien  Seizure - European Journal of Epilepsy 
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: Continuous spikes and waves during sleep is definitely a target 
Use and costs of concomitant medicines in epileptic patients in Poland: A 12-month prospective multicentre study  Beata Majkowska-Zwolińska, Joanna Jędrzejczak,
Evolution in VNS therapy for refractory epilepsy, experience with Demipulse devices at Ghent University Hospital  Riëm El Tahry, Veerle De Herdt, Robrecht.
Video ambulatory EEG: A good alternative to inpatient video telemetry?
Diego F. Tovar Quiroga, Jeffrey W. Britton, Elaine C. Wirrell 
Cyclical excitability of the motor cortex in patients with catamenial epilepsy: A transcranial magnetic stimulation study  Katja Hattemer, Susanne Knake,
Presentation transcript:

Outcomes of vagal nerve stimulation in a pediatric population: A single center experience  Camilla Yu, Sriram Ramgopal, Mark Libenson, Imane Abdelmoumen, Christine Powell, Kyle Remy, Joseph R. Madsen, Alexander Rotenberg, Tobias Loddenkemper  Seizure - European Journal of Epilepsy  Volume 23, Issue 2, Pages 105-111 (February 2014) DOI: 10.1016/j.seizure.2013.10.002 Copyright © 2013 British Epilepsy Association Terms and Conditions

Fig. 1 Consort diagram. Only patients with complete data at baseline, month 6, and month 12 were included in statistical analysis. Sixty-nine patients were included. *Search using ICD-9 codes used returned some patients who did not undergo VNS implantations, but who underwent similar procedures for treatments in otolaryngology. Seizure - European Journal of Epilepsy 2014 23, 105-111DOI: (10.1016/j.seizure.2013.10.002) Copyright © 2013 British Epilepsy Association Terms and Conditions

Fig. 2 Percentage change of seizures from baseline to 6 months. Patients in the low baseline group (Group 1) experienced a median seizure reduction of 25% (25% quartile, −50%; 75% quartiles, 50%) at 6 months (p=0.94). Patients in the high baseline group (Group 2) experienced a median seizure reduction of 61% (25% quartile, −93%; 75% quartile, −50%) at 6 months (p<0.001). Seizure - European Journal of Epilepsy 2014 23, 105-111DOI: (10.1016/j.seizure.2013.10.002) Copyright © 2013 British Epilepsy Association Terms and Conditions

Fig. 3 Percentage change of seizures from baseline to 12 months. Patients in the low baseline group (Group1) experienced a median seizure reduction of 0% (25% quartile, −50%; 75% quartiles, 100%) at 12 months (p=0.39). Patients in the high baseline group (Group 2) experienced a median seizure reduction of 69% (25% quartile, −96%; 75% quartile, −30%) at 12 months (p<0.001). Seizure - European Journal of Epilepsy 2014 23, 105-111DOI: (10.1016/j.seizure.2013.10.002) Copyright © 2013 British Epilepsy Association Terms and Conditions